Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Roch-Santed"'
Autor:
Pablo Sánchez-Sancho, Carlos-Javier Parramon-Teixidó, José-Manuel Del-Rio-Gutiérrez, Bruno Montoro, Alba Pau-Parra, Maria Roch-Santed, Carla Alonso-Martínez, Laura Gómez-Ganda, Laura Domènech, Carla Sans-Pola, M Miarons, Maria-Queralt Gorgas-Torner, Lluis Castells, Andrés Antón, Santiago Pérez-Hoyos, Ibai Los-Arcos, Maria Larrosa-Garcia, Carlota Varón-Galcera, Sonia Garcia-Garcia, Ariadna Gracia-Moya, Javier Varela, Patricia García-Ortega, Alfredo Guillén-Del-Castillo, Francesc Moreso, Cristina Berastegui, Javier Martínez-Casanova
Publikováno v:
Transplantation
Background The epidemiological and clinical characteristics of solid organ transplant (SOT) patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic remains unclear. We conducted a matched retrospective cohort study t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe21100774967c853548343c6bc40c34
Autor:
Maria Josep Cabañas Poy, Maria Roch Santed, Aurora Fernández Polo, Carme Cañete Ramírez, Susana Clemente Bautista, Mireia Del Toro Riera
Publikováno v:
European Journal of Hospital Pharmacy. 24:185-188
Case A child with Niemann-Pick disease type C was started on miglustat therapy at the age of 2 years. Intrathecal administration of hydroxypropyl-β-cyclodextrin was added 5 months later. The initial dose of 175 mg was gradually increased over the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::364b6be39d5cbee3af42ac3f0fa3c0d5
https://doi.org/10.1136/ejhpharm-2016-001067
https://doi.org/10.1136/ejhpharm-2016-001067
Autor:
Maria Roch-Santed, Juan C. Juárez-Giménez, David Brandariz-Núñez, Celia González-Guerrero, Jose B. Montoro-Ronsano, Lourdes Pastó-Cardona, Lucas Rivera-Sánchez, Toni Lozano-Andreu
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 28(1)
The aim of the study was to assess the influence of fibrinogen concentrate on survival when it is used in trauma patients with life-threatening hemorrhagic disorders. Secondly, to evaluate when the fibrinogen concentrate administration maximizes its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ee0bedba34dcfbf7ec89704c9b234f
https://pubmed.ncbi.nlm.nih.gov/27254440
https://pubmed.ncbi.nlm.nih.gov/27254440